Strabismus as the first symptom of severe congenital disorders
Strabismus is a disorder in which the two eyes are not aligned. The most common form of strabismus is known as «cross-eyed». In most cases it is harmless and can be corrected. In these cases, the genetic cause is a combination of polymorphisms that are not yet fully described. However, in some cases, strabismus […]
The College of Biologists of Catalonia (CBC) awards the distinction of «Collegiate of Honor» to Dr. Roser González-Duarte
The College of Biologists of Catalonia (CBC) has held (04.21.23) the 6th edition of the Biologist’s Day Awards. The emeritus professor of genetics and co-founder of DBGen Roser González-Duarte has been awarded as Collegiate of Honor, a category that distinguishes people who have increased the prestige of the profession due to their academic and scientific […]
DBGen Fifth Anniversary and Summary of 2022
A new year begins and DBGen wants to commemorate the arrival of the New Year by highlighting the main professional events and advances and acknowledging the contribution of all our patients and collaborators . External Recognitions: At DBGen we stand firmly in our commitment to offer high-quality, reliable and affordable genetic diagnosis. One year […]
DBGen participates in the 9th Congress of the Pan American Retina and Vitreous Society (11/15-18/2022)
DBGen participates in the ninth congress of the Pan American Retina and Vitreous Society (SPRV) in Argentina with the presentation «Leber’s Congenital Amaneurosis by RPE65 in Argentina».
DBGen participates in EURETINA 2022
DBGen has been in the EURETINA Congress 2022, which was held this year in Hamburg. This congress gathers the last advances in research in the area of visual pathologies. Dr. Rebeca Valero presented two complex cases which were diagnosed in DBGen by a combination of next generation sequencing techniques. The abstract of this work, «NGS technologies […]
DBGen fourth anniversary and summary of the year
Advances in genetic diagnosis This year, DBGen has expanded its genetic diagnostic services by presenting 3 new panels and incorporating state-of-the-art massive sequencing methodologies (complete genome sequencing). Three new panels: Panel of Dysgenesis and Dystrophies of the Anterior Segment (136 genes): indicated for the diagnosis of anomalies of the anterior part of the eye (from the […]
DBGen awarded an EASI-Genomics grant for innovative long-read sequencing of inherited retinal dystrophies
The Transnational Access Committee of the European Advanced infraStructure for Innovative Genomics (EASI-Genomics) has selected the project PID15251 submitted by DBGen Ocular Genomics in the third call for projects of this initiative. DBGen’s proposal has successfully passed the scientific and technical evaluation steps of this highly competitive call. EASI-Genomics is an initiative, funded with 10 million euros by the […]
DBGen’s genetic diagnosis of hereditary eye diseases tops the 1,000 patients figure
We are glad to announce that early this year DBGen Ocular Genomics has achieved more than 1,000 genetic diagnoses of hereditary visual disorders. The genetic diagnosis of hereditary eye diseases is not without a high degree of complexity. Over 270 genes associated with inherited retinal dystrophies (IRDs) and more than 500 genes associated with visual […]
DBGen second anniversary and summary of the year
DBGen Ocular Genomics is a spin-off of the University of Barcelona specialized in the genetic diagnosis of hereditary eye disorders. It was founded in January 2018 by Roser Gonzàlez-Duarte and Gemma Marfany, both senior scientists focussed in human molecular genetics, particularly in the genetic basis of ocular disorders. DBGen Ocular Genomics aims to provide an […]
DBGen presents a research optimizing the genetic diagnosis of color vision deficiency
DBGen is committed to the quality of genetic diagnosis and its major goal since the beginning of the company is to remain at the forefront of innovation, prioritize resolution of difficult cases, and optimize methodologies that increase the diagnostic yield of inherited ocular diseases. These objectives are clearly attainable due to the high expertise in […]